The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety of trastuzumab emtansine (T-DM1) in 373 patients 65 years or older with HER2-positive advanced breast cancer: A subgroup analysis of the Kamilla study.
 
Carlos H. Barrios
Honoraria - Boehringer Ingelheim; Eisai; GlaxoSmithKline; Novartis; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Eisai; GlaxoSmithKline; Novartis; Pfizer; Roche/Genentech
Research Funding - Amgen; AstraZeneca; Boehringer Ingelheim; Celgene; Eisai; GlaxoSmithKline; Lilly; Novartis; Pfizer; Roche/Genentech; Sanofi
 
Antonio Anton
No Relationships to Disclose
 
Suzette Delaloge
Honoraria - Novartis; Roche Pharma AG
Consulting or Advisory Role - Novartis; Pfizer; Roche Pharma AG
Research Funding - Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; Novartis; Roche Pharma AG
 
Filippo Montemurro
Speakers' Bureau - AstraZeneca; Novartis; Proacta
 
Rachel Wuerstlein
Consulting or Advisory Role - Roche Pharma AG
Research Funding - Roche Pharma AG
 
Stephen Robb
Employment - Roche Pharma AG
Stock and Other Ownership Interests - Roche Pharma AG
 
Peter Button
Employment - Roche Pharma AG
 
Paul Anthony Ellis
Travel, Accommodations, Expenses - Roche Pharma AG